Author: Zacks Small Cap Research

19394959697950 / 966 POSTS
By Brian Marckx, CFA NYSE:VNRX Q3 Results / Operational and Business Update: VolitionRx (NYSE:VNRX) reported Q3 results and provided a business update.  Relative to the financials, results were very much inline with our estimates (we note t ...
OTC:VIBI Vilacto Bio (OTC:VIBI) skin creams are a new entry into the US skin care marketplace having crossed the Atlantic from Denmark where they have been available for several years.  The brand is trying to leverage recent trends which have ...
By Ian Gilson, PhD, CFA NASDAQ:ESDI In a conference call today John Rich discussed the plans for the early 2018 roll-out of the  Redneck Riviera whisky. He will personally tour the SE USA with his band promoting the brand. He will be discussing ...
By M. Marin OTC:STVI Snap Interactive (OTC:STVI) recently announced a strategy to leverage the benefits of blockchain technology. The blockchain is a decentralized and encrypted “ledger” that offers a secure method to store records and other informat ...
By Brian Marckx, CFA  NASDAQ:CTSO Q3 Financials / Operating Update: Germany Reimbursement Rebounds, Drives Strong Record Product Sales…  CytoSorbents (NASDAQ:CTSO) reported financial results for their third quarter ending September 30th an ...
By Anita Dushyanth, PhD NASDAQ:VRAY Financial UpdateOn November 13, 2017 VRAY (NASDAQ:VRAY) announced third quarter financial results.The firm recorded revenue of little over $12 million for the quarter.  Management had originally guided for tot ...
By David Bautz, PhD NASDAQ:SPHS Financial UpdateOn November 9, 2017, Sophiris Bio, Inc. (NASDAQ:SPHS) announced financial results for the third quarter of 2017. As expected, the company did not report any revenues during the quarter. The company rep ...
By Brian Marckx, CFA NASDAQ:CASM Q3 Financial ResultsCAS Medical (NASDAQ:CASM) reported financial results for the third quarter ending September 30th.  Revenue was very much inline with our number and a relatively healthy beat on both gross marg ...
By Brian Marckx, CFA NASDAQ:CEMI Q3 2017: Upside from Lateral Flow OTC. DPP HIV/Syph, Several DPP Fever Products to Drive 2018 Growth …Chembio (NASDAQ:CEMI) reported Q3 2017 financial results and provided a business update.  Relative to our esti ...
By Ian Gilson, PhD, CFA NASDAQ:ESDI During a conference call Eastside Distilling (NASDAQ:ESDI) management and John Rich outlined the opportunities for the joint venture of Eastside and Rich Marks. Rich Marks is an established name in the U.S.A. ...
19394959697950 / 966 POSTS